TAN Xi,CHEN Lianjun,WU Zhouwei,et al.Clinical efficacy and mechanism of Yiqi Qubai Granules combined with filiform‑fire needle therapy in treating stable non⁃segmental vitiligo[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(3):61-63.
TAN Xi,CHEN Lianjun,WU Zhouwei,et al.Clinical efficacy and mechanism of Yiqi Qubai Granules combined with filiform‑fire needle therapy in treating stable non⁃segmental vitiligo[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(3):61-63. DOI: 10.16305/j.1007-1334.2025.z20240521007.
Clinical efficacy and mechanism of Yiqi Qubai Granules combined with filiform‑fire needle therapy in treating stable non⁃segmental vitiligo
To observe the clinical efficacy of Yiqi Qubai Granules (oral intake) combined with filiform-fire needle therapy in treating stable non-segmental vitiligo.
Methods
2
A total of 62 patients with stable non-segmental vitiligo were randomly divided into an experimental group (
n
=32) and a control group (
n
=30). Patients in both groups were treated with Yiqi Qubai Granules orally, and those in the experimental group additionally received localized treatment with filiform-fire needle the
rapy. The treatment lasted for 12 weeks. Clinical efficacy was observed, and changes in the scores of Dermatology Life Quality Index (DLQI) and Patient Health Questionnaire (PHQ-9), as well as in the peripheral blood C-X-C motif chemokine ligand 10 (CXCL10) expression level, were compared before and after treatment.
Results
2
①The total clinical effective rate was 43.8% in the experimental group and 26.7% in the control group, while the repigmentation rates were (49.8±27.7)% and (34.8±24.4)% in the two groups, respectively. The differences were statistically significant (
P
<
0.05). ②Intra-group comparisons before and after treatment showed a significant reduction in DLQI scores for both groups (
P
<
0.05). In the experimental group, the PHQ-9 score decreased significantly (
P
<
0.05), while in the control group, the decrease in PHQ-9 score was not statistically significant (
P
>
0.05). ③Intra-group comparisons before and after treatment showed a significant decrease in peripheral blood CXCL10 expression level in both groups (
P
<
0.05). Inter-group comparisons after treatment revealed that the CXCL10 expression level was significantly lower in the experimental group than in the control group (
P
<
0.05).
Conclusion
2
The combination of Yiqi Qubai Granules and filiform-fire needle therapy is effective in promoting repigmentation, improving patients' quality of life, and alleviating depressive symptoms in stable non-segmental vitiligo patients.
关键词
Keywords
references
OBENG-ASUMENG C , RODRIGUEZ-BOLANOS F , GOODERHAM M . Real-World experience of vitiligo patients:A retrospective chart review [J]. J Cutan Med Surg , 2024 , 28 ( 2 ): 134 - 135 .
BIBEAU K , EZZEDINE K , HARRIS J E , et al . Mental health and psychosocial quality-of-life burden among patients with vitiligo:Findings from the global valiant study [J]. JAMA Dermatol , 2023 , 159 ( 10 ): 1124 - 1128 .
WANG X X , WANG Q Q , WU J Q , et al . Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo [J]. Br J Dermatol , 2016 , 174 ( 6 ): 1318 - 1326 .
EL-DOMYATI M , EL-DIN W H , REZK A F , et al . Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome [J]. Arch Dermatol Res , 2022 , 314 ( 3 ): 275 - 284 .
Clinical study of electroacupuncture at bladder Mu point group for treating female stress urinary incontinence
Research progress on regulation of ferroptosis by traditional Chinese herbal medicine in treatment of metabolic dysfunction⁃associated steatotic liver disease
Exploring effect of acupuncture "treating the spirit" on sensation of Deqi based on correlation dimension characteristics of electrooculogram signals
Research progress of traditional Chinese medicine regulating ferroptosis in intervention of Alzheimer's disease
Clinical observation of Jinfukang Oral Liquid combined with adjuvant chemotherapy in treating postoperative patients with early to mid⁃stage non⁃small cell lung cancer and qi⁃yin deficiency syndrome
Related Author
SONG Xiuling
LIU Lumin
MING Shuren
GUAN Lixin
WANG Xi
HU Junwei
CHEN Yuelai
JIANG Yuzi
Related Institution
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine
Department of Hepatology,Shanghai Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine
Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine